Streptomyces spectabilis
| Streptomyces spectabilis | |
|---|---|
Scientific classification 
| |
| Domain: | Bacteria |
| Phylum: | Actinomycetota |
| Class: | Actinomycetia |
| Order: | Streptomycetales |
| Family: | Streptomycetaceae |
| Genus: | Streptomyces |
| Species: | S. spectabilis
|
| Binomial name | |
| Streptomyces spectabilis Mason et al. 1961[1]
| |
| Type strain | |
| ATCC 27465, BCRC 12648, CBS 725.72, CBS 725.75, CCRC 12648, CECT 3146, CECT 3156, DSM 40512, DSMZ 40512, IFO 13424, IFO 15441, ISP 5512, JCM 4308, JCM 4832, KCC S-0308, KCC S-0832, KCCS-0308, KCCS-0832, KCTC 9218, LMG 5986, MR ISP-5512, NBIMCC 70, NBRC 13424, NBRC 15441, NCAIM B.01936, NCIB 9733, NCIMB 9733, NRRL 2494, NRRL B-2494, NRRL-ISP 5512, RIA 1385[2] | |
Streptomyces spectabilis is a bacterium species from the genus of Streptomyces.[1][3][4] Streptomyces spectabilis produces hangtaimycin, gentamicin, kanamycin, neomycin B, sisomycin, tobramycin, paromomycin, spectinabilin, spectinomycin, aminocyclitol, actinospectacin, prodigiosine and the streptovaricin complex.[4][5][6][7][8][9][10]
Further reading
[edit]- Kim, Kyoung-Rok; Kim, Tae-Jong; Suh, Joo-Won (29 July 2008). "The Gene Cluster for Spectinomycin Biosynthesis and the Aminoglycoside-Resistance Function of spcM in Streptomyces spectabilis". Current Microbiology. 57 (4): 371–374. doi:10.1007/s00284-008-9204-y. PMID 18663525. S2CID 35278973.
- Isaka, M.; Jaturapat, A.; Kramyu, J.; Tanticharoen, M.; Thebtaranonth, Y. (1 April 2002). "Potent In Vitro Antimalarial Activity of Metacycloprodigiosin Isolated from Streptomycesspectabilis BCC 4785". Antimicrobial Agents and Chemotherapy. 46 (4): 1112–1113. doi:10.1128/AAC.46.4.1112-1113.2002. PMC 127104. PMID 11897600.
- HOEKSEMA, HERMAN; KNIGHT, JOHN C. (1975). "The production of dihydrospectinomycin by Syreptomyces spect abilis". The Journal of Antibiotics. 28 (3): 240–241. doi:10.7164/antibiotics.28.240. PMID 123898.
- Selvakumar, JN; Chandrasekaran, SD; Vaithilingam, M (October 2015). "Bio Prospecting of Marine-derived Streptomyces spectabilis VITJS10 and Exploring its Cytotoxicity Against Human Liver Cancer Cell Lines". Pharmacognosy Magazine. 11 (Suppl 3): S469–73. doi:10.4103/0973-1296.168974. PMC 4745219. PMID 26929583.
- Staley, AL; Rinehart, KL (December 1994). "Spectomycins, new antibacterial compounds produced by Streptomyces spectabilis: isolation, structures, and biosynthesis". The Journal of Antibiotics. 47 (12): 1425–33. doi:10.7164/antibiotics.47.1425. PMID 7844036.
- Atta-ur-Rahman, edited by (2000). Bioactive natural products. Amsterdam: Elsevier. ISBN 978-0-08-054202-7.
{{cite book}}:|first1=has generic name (help) - ed.-in-chief, George M. Garrity (2012). Bergey's manual of systematic bacteriology (2nd ed.). New York: Springer Science + Business Media. ISBN 978-0-387-68233-4.
{{cite book}}:|last1=has generic name (help) - Arya, Dev P. (2007). Aminoglycoside antibiotics from chemical biology to drug discovery. Hoboken, N.J.: Wiley-Interscience. ISBN 978-0-470-14966-9.
- Brossi, Arnold, ed. (1985). The alkaloids chemistry and pharmacology. Orlando: Academic Press. ISBN 978-0-08-086549-2.
- Corcoran, John W., ed. (1981). Biosynthesis. Berlin, Heidelberg: Springer Berlin Heidelberg. ISBN 978-3-642-67724-3.
- Stephen W., Queener (1986). Antibiotic- Producing Stetomyces. Oxford: Elsevier Science. ISBN 978-0-323-16293-7.
See also
[edit]References
[edit]- ^ a b LPSN bacterio.net
- ^ Straininfo of Streptomyces spectabilis
- ^ UniProt
- ^ a b Deutsche Sammlung von Mikroorganismen und Zellkulturen [1]
- ^ Kakinuma, K.; Hanson, C.A.; Rinehart, K.L. (January 1976). "Spectinabilin, a new nitro-containing metabolite isolated from streptomyces spectabilis". Tetrahedron. 32 (2): 217–222. doi:10.1016/0040-4020(76)87004-4.
- ^ editors, Satinder Kaur Brar, Gurpreet Singh Dhillon, Carlos Ricardo Soccol (2014). Biotransformation of Waste Biomass into High Value Biochemicals. New York, NY: Springer New York. ISBN 978-1-4614-8005-1.
{{cite book}}:|last1=has generic name (help)CS1 maint: multiple names: authors list (link) - ^ editors, Thomas J. Dougherty, Michael J. Pucci (2012). Antibiotic discovery and development (2012. ed.). New York: Springer. ISBN 978-1-4614-1400-1.
{{cite book}}:|last1=has generic name (help)CS1 maint: multiple names: authors list (link) - ^ Mordarski, edited by M. Goodfellow, S.T. Williams, M. (1988). Actinomycetes in Biotechnology. Oxford: Elsevier Science. ISBN 978-0-08-098433-9.
{{cite book}}:|first1=has generic name (help)CS1 maint: multiple names: authors list (link) - ^ J., Elks (1990). Dictionary of Drugs Chemical Data, Structures and Bibliographies. Boston, MA: Springer US. ISBN 978-1-4757-2085-3.
- ^ Zuo, Lijie; Jiang, Bingya; Jiang, Zhibo; Zhao, Wei; Li, Shufen; Liu, Hongyu; Hong, Bin; Yu, Liyan; Zuo, Limin; Wu, Linzhuan (9 March 2016). "Hangtaimycin, a peptide secondary metabolite discovered from Streptomyces spectabilis CPCC 200148 by chemical screening". The Journal of Antibiotics. 69 (11): 835–838. doi:10.1038/ja.2016.29. PMID 26956796. S2CID 22307941.
External links
[edit]
 | This Streptomyces-related article is a stub. You can help Wikipedia by expanding it. |